Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat
- 1 October 2010
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 235 (10), 1244-1256
- https://doi.org/10.1258/ebm.2010.010082
Abstract
Alimentary tract (AT) mucositis is a serious and debilitating side-effect of cancer therapy primarily characterized by damage of the mucous membranes throughout the AT. It is well established that this damage is a result of up-regulation of stress response genes and pro-inflammatory cytokines. Matrix metalloproteinases (MMPs) have been shown to function in several of the pathways known to be up-regulated in mucositis and play a key role in tissue injury and inflammation in many gastrointestinal disorders. This study aims to characterize the expression of multiple MMPs including MMP-1, -2, -3, -9 and -12 and their inhibitors, tissue inhibitor of metalloproteinase (TIMP)-1 and -2, in a rat model of irinotecan-induced mucositis. Dark agouti rats were administered a single 200 mg/kg intraperitoneal dose of irinotecan and killed at 1, 6, 24, 48, 72, 96 and 144 h following treatment. Hematoxylin and eosin staining, immunohistochemistry and realtime polymerase chain reaction were used to assess histopathological damage and MMP expression in the jejunum and colon. Marked histopathological evidence of mucositis was observed in the jejunum and colon as early as six hours following irinotecan treatment. A significant alteration in both gene expression and tissue levels of MMPs and TIMPs was noted following irinotecan. The increase in MMP-2, -3, -9 and -12 levels was associated with inflammatory infiltrate and maximum tissue damage. In contrast, MMP-1 expression correlated with tissue restitution. TIMP-1 and -2 levels were significantly altered in the jejunum following irinotecan. The augmentation in the expression profiles of MMPs and their inhibitors correlated with histopathological alterations observed in the tissue following irinotecan. This prompts the consideration of MMPs as possible mediators of chemotherapy-induced mucositis.This publication has 34 references indexed in Scilit:
- Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tractToxicology, 2010
- Irinotecan‐induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profileInternational Journal of Experimental Pathology, 2009
- Changes in Gene Expression of Matrix Constituents with Respect to Passage of Ligament and Tendon FibroblastsAnnals of Biomedical Engineering, 2008
- Tumor necrosis factor-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-κB in A549 cellsToxicology and Applied Pharmacology, 2008
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2008
- Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapyInternational Journal of Cancer, 2007
- Wnt Signaling Induces Matrix Metalloproteinase Expression and Regulates T Cell TransmigrationImmunity, 2007
- The effect of IL-1α on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cellsLife Sciences, 2006
- Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoeaThe Lancet Oncology, 2005
- Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healingScandinavian Journal of Gastroenterology, 2004